TY - JOUR AU - Young, Susan AU - Hollingdale, Jack AU - Absoud, Michael AU - Bolton, Patrick AU - Branney, Polly AU - Colley, William AU - Craze, Emily AU - Dave, Mayuri AU - Deeley, Quinton AU - Farrag, Emad AU - Gudjonsson, Gisli AU - Hill, Peter AU - Liang, Ho-lan AU - Murphy, Clodagh AU - Mackintosh, Peri AU - Murin, Marianna AU - O’Regan, Fintan AU - Ougrin, Dennis AU - Rios, Patricia AU - Stover, Nancy AU - Taylor, Eric AU - Woodhouse, Emma PY - 2020 DA - 2020/05/25 TI - Guidance for identification and treatment of individuals with attention deficit/hyperactivity disorder and autism spectrum disorder based upon expert consensus JO - BMC Medicine SP - 146 VL - 18 IS - 1 AB - Individuals with co-occurring hyperactivity disorder/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) can have complex presentations that may complicate diagnosis and treatment. There are established guidelines with regard to the identification and treatment of ADHD and ASD as independent conditions. However, ADHD and ASD were not formally recognised diagnostically as co-occurring conditions until the Diagnostic and Statistical Manual of Mental Disorders 5 (DSM-5) was published in 2013. Hence, awareness and understanding of both conditions when they co-occur is less established and there is little guidance in the clinical literature. This has led to uncertainty among healthcare practitioners when working with children, young people and adults who present with co-existing ADHD and ASD. The United Kingdom ADHD Partnership (UKAP) therefore convened a meeting of professional experts that aimed to address this gap and reach expert consensus on the topic that will aid healthcare practitioners and allied professionals when working with this complex and vulnerable population. SN - 1741-7015 UR - https://doi.org/10.1186/s12916-020-01585-y DO - 10.1186/s12916-020-01585-y ID - Young2020 ER -